CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

FIRST MANHATTAN CO. LLC.'s Holding History (CIK: 0000728083)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 152,200 Value ($000) $4,526 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 152,200 Value ($000) $2,743 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 152,200 Value ($000) $2,444 Avg Close $18.51 Range $15.23 - $21.65
Q4 2022
Shares 152,200 Value ($000) $2,785 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 152,200 Value ($000) $2,989 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 152,200 Value ($000) $2,838 Avg Close $19.96 Range $15.91 - $27.86
Q1 2022
Shares 152,200 Value ($000) $3,340 Avg Close $20.24 Range $16.53 - $28.95
Q2 2019
Shares 188 Value ($000) $4 Avg Close $24.76 Range $21.27 - $28.80
Q1 2019
Shares 188 Value ($000) $4 Avg Close $24.58 Range $21.05 - $30.61